NPI registry status
Active
2026 NPPES data Podiatrist NPI 1326244518 DPM
Verify on CMS → Anna Samolkin, DPM
Podiatrist in Livingston, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,602 in Podiatrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 263 beneficiaries · Podiatrist avg: 320
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 84 pts below national avg 83.5 · Penalty band
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Anna Samolkin, DPM reported a CMS MIPS final score of 0/100 - below the 83.5 national average - and filed 1,491 Medicare Part D claims in 2024.
- 0/100
- MIPS score · -83 vs avg
- 1K
- Part D claims, 2024
- 93%
- generic prescribing
- ≥0th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Anna Samolkin, DPM
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1326244518), first enumerated 06/25/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,491 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 0/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1326244518 · Podiatrist
NPI-10 · ENUM-MID · TAX-MID · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1326244518
- ENUM-MID 2007
- TAX-MID 11K Podiatrist
- MIPS-LOW 0/100
- RX-MID 1,491
- BOOK-LIGHT 526 in New Jersey
- PHOTO-FINISH Keith Arbuckle · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Samolkin · this … 0
Samolkin · this provider
0 MIPS pts
- Robert Buckenber… 0
Robert Buckenberger
0 MIPS pts
- Keith Arbuckle ·… 0
Keith Arbuckle
0 MIPS pts
- David Bates · near 0
David Bates
0 MIPS pts
- James Bowman · n… 0
James Bowman
0 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Anna Samolkin, DPM's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
0 ≥ 0th percentile 0% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Anna Samolkin, DPM sits
This provider among podiatrist peers
Across the 2,362 podiatrist providers who report both Medicare Part D prescribing and a MIPS quality score, Anna Samolkin, DPM writes more Part D claims than 98% of them and scores higher on MIPS quality than 0% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one podiatrist peer from a representative sample of 60; the gold marker is Anna Samolkin, DPM. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Anna Samolkin, DPM?
Below national averagePrimary specialty
Podiatrist
Medicare Part D claims
1,491 366% vs specialty avg
MIPS final score
0/100 83.5 pts vs avg
Specialty distribution in New Jersey
How Podiatrist compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Anna Samolkin, DPM's 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 0/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1326244518 |
|---|---|
| Specialty | Podiatrist |
| Credentials | DPM |
| Gender | Female |
| NPI Issued | 06/25/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
0
Final Score
Measured-score avg: 83.5
0
Quality
Reporting: Individual
Brand vs generic prescribing mix · Generic-heavy
Anna Samolkin, DPM - brand share 7.0%
Podiatrist average
7% brand-name claims vs 93% generic, on 1,491 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,491
Total Claims
$225K
Total Drug Cost
263
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,519.033
- Total Day Supply
- 41,812
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $137K
- Generic Drug Cost
- $88K
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 77.1 years
- Avg HCC Risk Score
- 1.73
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 12, 65-74: 89, 75-84: 99, 85+: 63
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Anna Samolkin, DPM prescribes most
Top Medicare Part D drugs by claim count, 2024
- Mupirocin
Mupirocin
527 claims
- Clotrimazole
Clotrimazole
292 claims
- Ammonium Lactate
Ammonium Lactate
244 claims
- Ketoconazole 124
Ketoconazole
124 claims
- Diclofenac Sodium 107
Diclofenac Sodium
107 claims
- Opzelura 35
Opzelura
35 claims
- Jublia 28
Jublia
28 claims
- Triamcinolone Acet… 18
Triamcinolone Acetonide
18 claims
| Drug | Claims |
|---|---|
| Mupirocin | 527 |
| Clotrimazole | 292 |
| Ammonium Lactate | 244 |
| Ketoconazole | 124 |
| Diclofenac Sodium | 107 |
| Opzelura Ruxolitinib Phosphate | 35 |
| Jublia Efinaconazole | 28 |
| Triamcinolone Acetonide | 18 |
| Silver Sulfadiazine | 17 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How Anna Samolkin, DPM fits within the Podiatrist landscape nationally.
10,602
Podiatrist Providers in US
54
States with Podiatrist
320
Avg Claims per Provider
Anna Samolkin, DPM's 1,491 claims are above the specialty average of 320.
Nationwide Podiatrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Samolkin, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (0 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Podiatrist Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Samolkin.
One of 526 Podiatrist providers enrolled in New Jersey, 5 are shown here.
Dr. Anthony Acello
DPM
Edison, NJ
Dr. Richard Adler
D.P.M.
Cherry Hill, NJ
Scott Agins
DPMD
Irvington, NJ
Dr. Maarij Ahmed
DPM
Marlton, NJ
Dr. Nafis Ahmed
DPM
Denville, NJ
Compare Podiatrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Anna Samolkin, DPM's specialty? ▼
Anna Samolkin, DPM specializes in Podiatrist and practices in Livingston, New Jersey. Credentials: DPM.
How much does Anna Samolkin, DPM prescribe under Medicare Part D? ▼
In 2024, Anna Samolkin, DPM wrote 1,491 Medicare Part D claims totaling $225K in drug costs for 263 beneficiaries.
What is Anna Samolkin, DPM's Medicare quality score? ▼
Anna Samolkin, DPM has a CMS MIPS Final Score of 0/100 (Quality: 0). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Anna Samolkin, DPM located? ▼
Anna Samolkin, DPM is located at 12 COUNTRYSIDE DR, Livingston, NJ, 07039. Phone: (973) 597-0230.
What is Anna Samolkin, DPM's NPI number? ▼
Anna Samolkin, DPM's National Provider Identifier (NPI) is 1326244518, issued on 06/25/2007.
Does Anna Samolkin, DPM prescribe more brand-name or generic drugs? ▼
Anna Samolkin, DPM's prescribing is 7% brand-name and 93% generic drugs by claim count, with $137K in brand drug costs.
How many Podiatrist providers are there in the US? ▼
There are 10,602 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 320 Medicare Part D claims per year.
What drugs does Anna Samolkin, DPM prescribe most often? ▼
Based on 2024 Medicare Part D data, Anna Samolkin, DPM's most frequently prescribed drugs include Mupirocin, Clotrimazole, Ammonium Lactate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Anna Samolkin, DPM accept Medicare? ▼
Anna Samolkin, DPM appears in CMS Medicare data with 1,491 Part D claims and 263 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Anna Samolkin, DPM's credentials? ▼
Anna Samolkin, DPM's NPI is 1326244518 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.